Published in Medical Device Law Weekly, March 4th, 2007
Adrovance reduces the risk of vertebral and hip fractures. MSD currently markets this product under the brand name Fosavance.
Under the terms of the agreement, Ipsen will source the product from MSD, market and sell it under the brand name Adrovance in France.
Christophe Jean, executive VP, chief operations officer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.